Compare NCLH & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NCLH | BIRK |
|---|---|---|
| Founded | 1966 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Marine Transportation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 8.5B |
| IPO Year | 2011 | 2023 |
| Metric | NCLH | BIRK |
|---|---|---|
| Price | $21.03 | $44.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 14 |
| Target Price | $24.76 | ★ $61.43 |
| AVG Volume (30 Days) | ★ 18.5M | 2.6M |
| Earning Date | 05-04-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $5,396,175,000.00 | N/A |
| Revenue This Year | $9.96 | $13.71 |
| Revenue Next Year | $6.60 | $14.30 |
| P/E Ratio | $88.65 | ★ $17.48 |
| Revenue Growth | ★ 10.71 | N/A |
| 52 Week Low | $14.53 | $31.33 |
| 52 Week High | $27.18 | $53.53 |
| Indicator | NCLH | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 65.08 | 53.38 |
| Support Level | $20.70 | $43.92 |
| Resistance Level | $24.69 | $45.80 |
| Average True Range (ATR) | 0.93 | 2.22 |
| MACD | 0.20 | -0.43 |
| Stochastic Oscillator | 91.66 | 33.22 |
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 71,000). It operates 34 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 17 passenger vessels on order among its brands through 2037, representing 46,000 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.